Hepatic subcapsular steatosis in response to intraperitoneal insulin delivery: CT findings and prevalence.
OBJECTIVE
The aim of this study was to investigate the CT findings and prevalence of hepatic subcapsular steatosis in patients undergoing peritoneal dialysis with intraperitoneal insulin delivery.


CONCLUSIONS
Hepatic subcapsular steatosis appeared as subcapsular nodules and often rindlike areas of low attenuation in seven (18%) of 39 patients who received intraperitoneal insulin with their peritoneal dialysate. Cessation of intraperitoneal insulin therapy led to reversal of the steatosis in three patients.
Khalili
Korosh
K
Department of Medical Imaging, University Health Network and Mount Sinai Hospitals, 200 Elizabeth St., Toronto, Ontario M4G 2C4, Canada.
Lan
Frederick P
FP
Hanbidge
Anthony E
AE
Muradali
Derek
D
Oreopoulos
Dmitrios G
DG
Wanless
Ian R
IR
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005218:Fat Necrosis / Q000000981:diagnostic imaging* / Q000453:epidemiology / Q000209:etiology*; D005234:Fatty Liver / Q000000981:diagnostic imaging* / Q000453:epidemiology / Q000209:etiology*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D007263:Infusions, Parenteral / Q000009:adverse effects*; D007328:Insulin / Q000008:administration & dosage* / Q000009:adverse effects*; D007676:Kidney Failure, Chronic / Q000150:complications / Q000000981:diagnostic imaging* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010530:Peritoneal Dialysis / Q000009:adverse effects; D015995:Prevalence; D015203:Reproducibility of Results; D014057:Tomography, X-Ray Computed
D007004:Hypoglycemic Agents; D007328:Insulin